Stock CMAX CAREMAX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus CareMax, Inc.

Equities

CMAX

US14171W2026

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/06/2024 BST 		5-day change 1st Jan Change
3.41 USD +79.47% Intraday chart for CareMax, Inc. +19.65% -77.18%
06-14 CareMax, Inc. Appoints Paul Rundell as Chief Restructuring Officer CI
05-15 CareMax, Inc. Enters into a Limited Waiver and Fourth Amendment to Credit Agreement CI

Evolution of the average Target Price on CareMax, Inc.

Price target over the last 5 years

History of analyst recommendation changes

33c3bc6540216.DLvwLGP9ubvPs9j4uWQe7cLfjDikELvKSph0eCJc9f4.YdaHdA6i-9n2gInM8RIv2KSF-EriQI2Zff4DNBoypLRL1t0ZJLTN1pDAkQ~46af8054ce9181aa37ff9916c65f4178

Analyst Recommendations on CareMax, Inc.

UBS Trims CareMax Price Target to $6.40 From $7, Maintains Neutral Rating MT
UBS Adjusts CareMax Price Target to $7 From $30, Maintains Neutral Rating MT
UBS Downgrades CareMax to Neutral From Buy, Adjusts Price Target to $1 From $5 MT
Piper Sandler Downgrades CareMax to Neutral From Overweight With $2 Price Target MT
UBS Adjusts CareMax Price Target to $5 From $6, Maintains Buy Rating MT
TD Cowen Downgrades CareMax to Market Perform From Outperform, Adjusts Price Target to $4 From $7 MT
UBS Adjusts CareMax's Price Target to $6 From $10, Maintains Buy Rating MT
UBS Adjusts CareMax Price Target to $10 From $11, Maintains Buy Rating MT
UBS Adjusts CareMax Price Target to $11 From $12, Maintains Buy Rating MT
Truist Securities Starts CareMax at Hold With $7.50 Price Target MT
UBS Adjusts CareMax Price Target to $12 From $13, Maintains Buy Rating MT
UBS Adjusts CareMax Price Target to $13 From $14, Maintains Buy Rating MT
UBS Initiates Coverage on CareMax With Buy Rating, $14 Price Target MT
CAREMAX : Jefferies Starts CareMax at Buy with $15 Price Target MT
CAREMAX : Piper Sandler Upgrades CareMax to Overweight From Neutral MT
CAREMAX : Cowen Starts CareMax at Outperform with $14 Price Target MT
CAREMAX : Piper Sandler Starts CareMax at Neutral With $14 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
3.41 USD
Average target price
4.7 USD
Spread / Average Target
+37.83%
High Price Target
6.4 USD
Spread / Highest target
+87.68%
Low Price Target
3 USD
Spread / Lowest Target
-12.02%

Consensus detail

Consensus revision (last 18 months)

Analysts covering CareMax, Inc.

UBS
Piper Sandler
TD Cowen
Truist Securities
Jefferies & Co.
Cowen

Ratings for CareMax, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. CMAX Stock
  4. Consensus CareMax, Inc.